Pacific Biosciences Of California (PACB) Work In Process (2011 - 2026)

Pacific Biosciences Of California's Work In Process history runs 16 years deep, the most recent figure standing at $27.3 million for Q1 2026.

• In Q1 2026, Work In Process rose 9.77% year-over-year to $27.3 million; the TTM figure through Mar 2026 stood at $27.3 million (up 9.77% YoY), while the FY2025 annual figure was $27.1 million, up 22.01% from the prior year.
• Work In Process was $27.3 million for Q1 2026 at Pacific Biosciences Of California, up from $27.1 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $27.9 million in Q3 2023 to a low of $9.2 million in Q1 2022.
• Historically, Work In Process has averaged $21.7 million across 5 years, with a median of $22.6 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Work In Process surged 135.87% in 2023, then slumped 34.4% in 2024.
• A 5-year view of Work In Process shows it stood at $14.1 million in 2022, then surged by 96.65% to $27.7 million in 2023, then declined by 19.82% to $22.2 million in 2024, then climbed by 22.01% to $27.1 million in 2025, then increased by 1.1% to $27.3 million in 2026.
• The last three Work In Process figures came in at $27.3 million (Q1 2026), $27.1 million (Q4 2025), and $25.2 million (Q3 2025), per Business Quant data.